MedTrace Logo

Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer

NCT00002544 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2013-08-02

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if mitoxantrone is more effective with or without docetaxel.

PURPOSE: Randomized phase III trial to compare the effectiveness of mitoxantrone with or without docetaxel in treating women who have metastatic breast cancer with a poor prognosis.

Conditions

Interventions

DRUG

docetaxel

DRUG

mitoxantrone hydrochloride

Sponsors & Collaborators

  • Arbeitsgemeinschaft fur Internistische Onkologie

    lead OTHER

Principal Investigators

  • Else G. Heidemann, MD · Diakonie-Klinikum Stuttgart

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-05-31
Completion
2002-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002544 on ClinicalTrials.gov